Skip to content

Arbidol

Arbidol is a Russian-produced antiviral product brand for the treatment and prevention of influenza and acute respiratory viral infections (ARVI).

Last updated September 15, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Arbidol is an antiviral product brand produced in Russia and presented on its official site as intended for the treatment and prevention of influenza and acute respiratory viral infections (ARVI). The brand's official materials state that it acts directly on viruses by blocking their entry into cells, their multiplication and spread, and describe a mechanism of inhibiting virus attachment to cells (fusion). The official site presents Arbidol in several dosage forms and strengths, including a suspension, tablets and capsules, with age-related dosing information.

Products and positioning

Antiviral product for the treatment and prevention of influenza and ARVI.

  • Arbidol suspension

    Suspension with a dosage of 25 mg (5 ml), indicated from 2 years of age.

  • Arbidol tablets

    Tablets with a dosage of 50 mg, indicated from 3 years of age; supplied as 10 or 20 tablets.

  • Arbidol capsules

    Capsules with a dosage of 100 mg, indicated from 6 years of age; supplied as 10 or 20 capsules.

  • Arbidol Maximum capsules

    Capsules with a dosage of 200 mg, indicated from 12 years of age; supplied as 10 or 20 capsules.

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/arbidol · Editorial policy · How profiles are compiled